• Which systemic therapy should I choose for HCC?
    Oct 16 2026

    Join Prof Ken Liu as we discuss the ins and outs of choosing different systemic therapy of HCC.


    Check out EASL Deepdive: https://open.spotify.com/episode/3QlE3JUpMjyGYCifmtHWyp


    Article discussed today: Immune checkpoint inhibitor-related hepatotoxicity: A review
    Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021; 27(32): 5376-5391 [PMID: 34539139 DOI: 10.3748/wjg.v27.i32.5376]


    https://www.wjgnet.com/1007-9327/full/v27/i32/5376.htm


    Show More Show Less
    12 mins
  • When should I refer to palliative care for patients with cirrhosis?
    Sep 4 2026

    Join Dr Richard Skoien and Dr Alison Kearney as we discuss the Hepatocare model and the importance of appropriate and timely palliative care referral.


    Scottish Guidelines:

    https://www.palliativecareguidelines.scot.nhs.uk/scottish-palliative-care-guidelines/last-days-of-life-care-around-dying/end-stage-liver-disease/


    Show More Show Less
    13 mins
  • When should I prescribe steroids for alcohol associated hepatitis?
    Aug 22 2026

    Join A/Prof Juan Pablo Arab as we discuss using steroids in alcohol associated hepatitis.


    Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 Nov;75(5):1026-1033. doi: 10.1016/j.jhep.2021.06.019. Epub 2021 Jun 21. PMID: 34166722; PMCID: PMC11090180.


    https://pubmed.ncbi.nlm.nih.gov/34166722/


    Show More Show Less
    9 mins
  • What is Met-ALD?
    Aug 7 2026

    Join A/Prof Juan Pablo Arab as we discuss what is Met-ALD.


    Article: https://www.journal-of-hepatology.eu/article/S0168-8278(24)02728-4/pdf


    Show More Show Less
    12 mins
  • Beta blockers in cirrhosis
    Jul 27 2026

    Join Dr Vaitiekunas as he interviews Prof Abraldes answering all the important questions regarding beta blockers in cirrhosis.


    Further reading: Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis


    https://www.sciencedirect.com/science/article/abs/pii/S0168827825025656


    Show More Show Less
    8 mins
  • SCUH Hepatology Fellowship
    Jun 8 2026

    nterested in one of the most unique and trainee focussed hepatology fellowships in Australia?
    Watch below ⬇️ ⬇️ ⬇️
    Opportunity to tailor your experience in:
    1. Dedicated HCC clinic including prescribing immunotherapy with incorporated clinical trials
    2. Specialised clinics in PBC and PSC-IBD
    3. Options to have specialised clinics in complex portal hypertension/advanced hepatology/MASLD/ARLD
    4. Dedicated experience as "consultant on the ward"
    5. Portal hypertension endoscopy lists
    6. Be part of multiple investigator and the latest phase 3 trials
    7. International collaborations
    8. Learn from experts in clinical, research and public health
    Join us at the Sunshine Coast. What are you waiting for?
    To apply: https://lnkd.in/gG9dy_GF
    Deadline: 16th June

    Show More Show Less
    4 mins
  • How to manage hyponatraemia in cirrhosis?
    Mar 13 2026

    Join A/Prof Eric Orman as we discuss management of hyponatraemia in cirrhosis?


    EASL: https://www.journal-of-hepatology.eu/article/S0168-8278(18)31966-4/fulltext


    AASLD: https://journals.lww.com/hep/fulltext/2021/08000/diagnosis,_evaluation,_and_management_of_ascites,.38.aspx


    AGA: https://www.gastrojournal.org/article/S0016-5085(25)05959-1/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F




    Show More Show Less
    5 mins
  • How to manage and prevent falls in cirrhosis?
    Feb 27 2026

    Join Prof Elliot Tapper discussing how to manage falls in cirrhosis.


    Article: Falls are an underappreciated driver of morbidity and mortality in cirrhosis

    https://journals.lww.com/cld/pages/articleviewer.aspx?year=2022&issue=11000&article=00002&type=Fulltext


    Show More Show Less
    5 mins